Trial Outcomes & Findings for Efficacy Study of Mindfulness-Based Exercise for Posttraumatic Stress Disorder (PTSD) (NCT NCT01462045)

NCT ID: NCT01462045

Last Updated: 2015-01-06

Results Overview

The PCL-C is a 17-item self-report instrument that measures the symptoms of PTSD. A total score, ranging from 17 to 85, is found by summing the scores of the 17 items. Higher values are considered to be a worse outcome. The inclusion criteria in the PTSD symptomatic group is a PCL-C total score of at least 28 with a score of 3 or higher on 1 or more items.To detect a reduction in PTSD symptom severity with a 2-sided 5% significance level and a power of 80%, the mean difference of PCL-C scores of 5.16 or greater requires a sample size of 20 participants for Exercise and Control groups, given an anticipated dropout rate of 10%. Data analyses are conducted using an a priori intention-to-treat approach. The analysis for the between-group differences of the intervention is conducted using t-tests comparing Exercise and Control groups at post-intervention. The analysis for the within-group difference is conducted using repeated measures ANOVA for both groups at baseline and week 8.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

29 participants

Primary outcome timeframe

Baseline and 8 weeks

Results posted on

2015-01-06

Participant Flow

Nurse volunteers were recruited from the University of New Mexico Hospital through advertisement,between September 1, 2011 and March 31, 2012.

Participants gave their informed written consent before participation. Inclusion criteria were age greater than 18 years and employment as a nurse at the University of New Mexico (UNM) Hospital. Exclusion criteria included an inability to participate in the exercise program, or current use of systemic glucocorticoid.

Participant milestones

Participant milestones
Measure
Exercise Group
Participants who are screened positive for PTSD and participate in the mindfulness-based exercise.
Control Group
Participants who are screened positive for PTSD but do not participate in the mindfulness-based exercise.
Base Group
Healthy volunteers who are not screened positive for PTSD and do not participate in the mindfulness-based exercise.
Overall Study
STARTED
11
11
7
Overall Study
COMPLETED
11
10
7
Overall Study
NOT COMPLETED
0
1
0

Reasons for withdrawal

Reasons for withdrawal
Measure
Exercise Group
Participants who are screened positive for PTSD and participate in the mindfulness-based exercise.
Control Group
Participants who are screened positive for PTSD but do not participate in the mindfulness-based exercise.
Base Group
Healthy volunteers who are not screened positive for PTSD and do not participate in the mindfulness-based exercise.
Overall Study
Family matter
0
1
0

Baseline Characteristics

Efficacy Study of Mindfulness-Based Exercise for Posttraumatic Stress Disorder (PTSD)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Exercise Group
n=11 Participants
Participants who are screened positive for PTSD and participate in the mindfulness-based exercise.
Control Group
n=11 Participants
Participants who are screened positive for PTSD but do not participate in the mindfulness-based exercise.
Base Group
n=7 Participants
Healthy volunteers who are not screened positive for PTSD and do not participate in the mindfulness-based exercise.
Total
n=29 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=39 Participants
0 Participants
n=41 Participants
0 Participants
n=35 Participants
0 Participants
n=31 Participants
Age, Categorical
Between 18 and 65 years
11 Participants
n=39 Participants
11 Participants
n=41 Participants
6 Participants
n=35 Participants
28 Participants
n=31 Participants
Age, Categorical
>=65 years
0 Participants
n=39 Participants
0 Participants
n=41 Participants
1 Participants
n=35 Participants
1 Participants
n=31 Participants
Age, Continuous
49 years
STANDARD_DEVIATION 6.4 • n=39 Participants
45 years
STANDARD_DEVIATION 9.9 • n=41 Participants
44 years
STANDARD_DEVIATION 15.1 • n=35 Participants
46 years
STANDARD_DEVIATION 10.1 • n=31 Participants
Sex: Female, Male
Female
10 Participants
n=39 Participants
11 Participants
n=41 Participants
7 Participants
n=35 Participants
28 Participants
n=31 Participants
Sex: Female, Male
Male
1 Participants
n=39 Participants
0 Participants
n=41 Participants
0 Participants
n=35 Participants
1 Participants
n=31 Participants
Region of Enrollment
United States
11 participants
n=39 Participants
11 participants
n=41 Participants
7 participants
n=35 Participants
29 participants
n=31 Participants

PRIMARY outcome

Timeframe: Baseline and 8 weeks

Population: For Base Group, the values entered represent the mean value of the baseline PCL-C scores. The mean difference score for the Base Group is not available because the Base Group was assessed only at baseline.

The PCL-C is a 17-item self-report instrument that measures the symptoms of PTSD. A total score, ranging from 17 to 85, is found by summing the scores of the 17 items. Higher values are considered to be a worse outcome. The inclusion criteria in the PTSD symptomatic group is a PCL-C total score of at least 28 with a score of 3 or higher on 1 or more items.To detect a reduction in PTSD symptom severity with a 2-sided 5% significance level and a power of 80%, the mean difference of PCL-C scores of 5.16 or greater requires a sample size of 20 participants for Exercise and Control groups, given an anticipated dropout rate of 10%. Data analyses are conducted using an a priori intention-to-treat approach. The analysis for the between-group differences of the intervention is conducted using t-tests comparing Exercise and Control groups at post-intervention. The analysis for the within-group difference is conducted using repeated measures ANOVA for both groups at baseline and week 8.

Outcome measures

Outcome measures
Measure
Exercise Group
n=11 Participants
Participants who are screened positive for PTSD and participate in the mindfulness-based exercise.
Control Group
n=11 Participants
Participants who are screened positive for PTSD but do not participate in the mindfulness-based exercise.
Base Group
n=7 Participants
Healthy volunteers who are not screened positive for PTSD and do not participate in the mindfulness-based exercise.
Change From Baseline in PTSD Checklist - Civilian Version (PCL-C) Score
-18.8 scores on a scale
Standard Deviation 10.6
-5.2 scores on a scale
Standard Deviation 15.8
21.8 scores on a scale
Standard Deviation 3.4

SECONDARY outcome

Timeframe: baseline and 8 weeks

Change from baseline in serum cortisol levels at 8 weeks. Serum cortisol samples were collected at 8:00 Ante Meridian (AM). The changes are calculated from two time points as the values at 8 weeks minus the values at baseline.

Outcome measures

Outcome measures
Measure
Exercise Group
n=11 Participants
Participants who are screened positive for PTSD and participate in the mindfulness-based exercise.
Control Group
n=11 Participants
Participants who are screened positive for PTSD but do not participate in the mindfulness-based exercise.
Base Group
n=7 Participants
Healthy volunteers who are not screened positive for PTSD and do not participate in the mindfulness-based exercise.
Cortisol
5.1 μg/dl
Standard Deviation 4.5
-0.7 μg/dl
Standard Deviation 6.5
-0.04 μg/dl
Standard Deviation 9.4

Adverse Events

Exercise Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Base Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Sang Hwan Kim, PhD/Lead Investigator

University of New Mexico

Phone: 5057954545

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place